SOP Logo

Currently Enrolled Graduate Students


 

Rafael Alfonso

Rafael Alfonso

Admission: Fall 2007

MD, Universidad del Rosario, Colombia
MSc, Universidad Autonoma de Barcelona, Spain

Research Interest: Evaluation of health policies, pharmacoeconomics and outcomes research in Latin American countries.


 

Deborah Atherly

Deborah Atherly, PhD Candidate

Admission: Fall 1999

MPH, University of Washington
BS, Pharmacy, University of Washington

Dissertation Title: Evaluation of the Costs and Health Effects of the Syphilis Rapid Immunochromatographic Strip (ICS) Test in Antenatal Screening Programs in Mozambique


Joseph Babigumira

Admission: Fall 2006

MS, Health Services Research, Case Western Reserve University
MBChB, Medicine and Surgery, Mbarara University, Uganda

Research Interests : To conduct cost-effectiveness research and to influence health policy in Uganda and other sub-Saharan countries

 


 

Mindy Cheng

Admission: Fall 2006

MS, Healthcare Administration, California State University, East Bay
BS, Microbiology, University of Michigan

Research Interests: Orphan drugs- economics and outcomes, pharmacoeconomics, health policy analysis, infectious disease diagnosis and treatment


 

Jamie Cross

Jamie Cross, PhD Candidate

Admission: Fall 2004

Fellow in Drug Development Science (Georgetown University)
MS Immunology (University of California, Davis)
BS Biology and French (Tufts University)

Dissertation Title: A Case Study and Policy Analysis of Novel Quantitative Methods for Drug Risk-Benefit Assessment in Regulatory Decision-Making
Research Interests: Risk-benefit analysis, decision-analysis, drug regulation and policy, improving the efficiency of clinical trial design and analysis for decision-making.

 


 

bernardo

Bernardo Goulart

Admission: Fall 2008

MD, Universidade Federal do Rio de Janiero

Research Interests: Clinical outcomes in lung and head and neck cancers; cost-effectiveness of lung and head and neck cancer therapies; cancer clinical trials.


 

gries

 

 

 

 

 

Katie Gries

Fellowship: 2008-2010

University of Washington/Allergan
Post-Doctoral Fellowship

PharmD, University of Southern California

Research Interests: Pharmaceutical outcomes; economic benefit of evidence based medicine, quality of life research that relates to drug treatment, cost-effectiveness analyses applies to oncology management


 

hansen

 

 

 

 

 


Ryan Hansen

Fellowship: 2007-2011

University of Washington/Abbott Laboratories
Pre-Doctoral Fellowship

PharmD, University of Washington

Research Interests: Health economics, cost-effectiveness analyses, health and disease state modeling.


 

Elizabeth James

Elizabeth James, PhD Candidate

Admission: Fall 2004

PharmD, University of Texas, Austin
BS Biomedical Sciences, Texas A&M University

Dissertation Title: Evaluation of a Prescription Drug Pay-for-Performance Program: Impact on prescribing trends, budget and patient outcomes
Research Interests: Pharmaceutical policy, pharmacy practice, health insurance prescription benefit structure, clinical trials


 

noriok

Norio Kasahara

Admission: Fall 2008

BS, Pharmacy, Tokyo University of Pharmacy & Life Sciences
MPH, Johns Hopkins University

Research Interests: Health policy analysis and pharmaceutical outcomes research; pharmaceutical regulations and policies, pharmacoeconomics, effectiveness analysis of pharmaceutical interventions, and global health.

 


 

Josh Roth

Joshua Roth

Admission: Fall 2008

MHA, University of Washington
BS, Experimental Psychology and Sociology, Union College,Schenectady, NY

Research Interests: Health technology assessment, Cost-effectiveness analysis in cancer therapeutics, Effects of changes in policy on cost and utilization of prescription medications


 

Eldon Spackman

D. Eldon Spackman

Admission: Fall 2005

MA, Health Economics, University of Calgary
BA Economics, University of Calgary

Dissertation Title: Health Economics Research in Alzheimer’s Disease: Support for Dependence as an Economic Outcome and the Development of a Model Evaluating the Cost-Effectiveness of Screening
Research Interests: cost-effectiveness analyses, modeling (Markov and Discrete Event Simulation) and health economics.


 

Jonathan Watanabe

Fellowship: 2007-2009

University of Washington/Allergan
Post-Doctoral Fellowship

PharmD, University of Southern California
MS, University of Washington

Thesis Title: Cost Analysis for Interventions for Antimuscarinic Refractory Patients with Overactive Bladder

Research Interests: Payer Cost and Reimbursement Analysis, Patient Reported Outcomes and Dossier submission to FDA, Health Related Quality of Life and Utility assessment,  Impact of Drug-Drug Interactions on Care


 

Catherine Waweru

Admission: Fall 2006

MSc, Clinical Pharmacy, University of London
BSc, Pharmacy, University of Nairobi, Kenya

Research Interests: To create policies that will improve access to necessary pharmaceuticals and health services for the the people of Kenya - particularly women and children.


 

heidiw

Heidi Wirtz

Admission: Fall 2008

BS, University of Iowa
MS, University of Iowa
PharmD, Creighton University

Reseach Interests: Cost-effectiveness analysis of biologics and health care technology, clinical trial design, Regulatory decision-making.


 

Jelena Zurovac

Admission: Fall 2006

PhD Student, Economics, University of Washington
BA, Economics, Smith College

Research Interests: Health and development economics, cost-effectiveness analysis


 

 


Pharmacy Home
|| Applying To The School || Contact Us

©2003-2007 University of Washington School of Pharmacy

This page was last updated March 25, 2009

UW Logo